Lipocine Inc.
Lipocine Inc. (LPCN) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · LPCN · as of Jun 9, 2026
Activity summary
Buy transactions
4
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Lipocine Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
LPCN insider buying and selling by quarter
LPCN insider selling · LPCN insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
LPCN executive sell shares · LPCN board member insider trading · LPCN insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 8, 2024 | Patel Mahesh V. CEO and President · Director | Award | 4,893 | — | Form 4 |
| Mar 8, 2024 | Fogarty Krista PAO | Award | 991 | — | Form 4 |
| May 25, 2023 | Patel Mahesh V. CEO and President · Director | Purchase | 8,706 | $44K | Form 4 |
| Mar 24, 2023 | Patel Mahesh V. CEO and President · Director | Purchase | 150,000 | $48K | Form 4 |
| Mar 20, 2023 | Ono Richard Dana Director | Purchase | 4,000 | $1K | Form 4 |
| Mar 17, 2023 | Patel Mahesh V. CEO and President · Director | Purchase | 50,000 | $17K | Form 4 |
| Nov 14, 2022 | Patel Mahesh V. CEO and President | Purchase | 75,000 | $29K | Form 4 |
| Sep 27, 2022 | Patel Mahesh V. CEO and President · Director | Purchase | 100,000 | $41K | Form 4 |
| May 17, 2022 | Fogarty Krista PAO | Purchase | 12,500 | $11K | Form 4 |
| May 16, 2022 | Patel Mahesh V. CEO and President | Purchase | 50,000 | $38K | Form 4 |
| Nov 18, 2021 | Patel Mahesh V. CEO and President · Director | Purchase | 25,000 | $27K | Form 4 |
| Dec 31, 2020 | Higuchi John W. Director | Sale | 1,700 | $2K | Form 4 |
| Dec 31, 2020 | Higuchi John W. Director | Sale | 5,000 | $7K | Form 4 |
| Dec 16, 2020 | Higuchi John W. Director | Option | 3,750 | — | Form 4 |
| Dec 16, 2020 | Ono Richard Dana Director | Option | 5,250 | — | Form 4 |
| Dec 16, 2020 | Fink Jeffrey Arvin Director | Option | 5,625 | — | Form 4 |
| Dec 16, 2020 | HILL STEPHEN A Director | Option | 7,500 | — | Form 4 |
| Dec 16, 2020 | Patel Mahesh V. CEO · Director | Option | 45,000 | — | Form 4 |
| Dec 16, 2020 | Patel Mahesh V. CEO · Director | Sale | 15,000 | $20K | Form 4 |
| Dec 16, 2020 | BROWN MORGAN R EVP and CFO | Option | 28,125 | — | Form 4 |
| Dec 16, 2020 | BROWN MORGAN R EVP and CFO | Sale | 8,437 | $11K | Form 4 |
| Dec 5, 2020 | Patel Mahesh V. CEO · Director | Option | 122,978 | — | Form 4 |
| Dec 4, 2020 | Patel Mahesh V. CEO · Director | Option | 145,000 | — | Form 4 |
| Dec 4, 2020 | Patel Mahesh V. CEO · Director | Sale | 43,500 | $68K | Form 4 |
| Dec 5, 2020 | BROWN MORGAN R CFO | Option | 70,754 | — | Form 4 |
Patel Mahesh V.
CEO and President · Director
Date
Mar 8
Shares
4,893
Price
—
Value
—
Patel Mahesh V.
CEO and President · Director
Date
May 25
Shares
8,706
Price
$5.03
Value
$44K
Patel Mahesh V.
CEO and President · Director
Date
Mar 24
Shares
150,000
Price
$0.32
Value
$48K
Patel Mahesh V.
CEO and President · Director
Date
Mar 17
Shares
50,000
Price
$0.33
Value
$17K
Patel Mahesh V.
CEO and President
Date
Nov 14
Shares
75,000
Price
$0.39
Value
$29K
Patel Mahesh V.
CEO and President · Director
Date
Sep 27
Shares
100,000
Price
$0.41
Value
$41K
Patel Mahesh V.
CEO and President
Date
May 16
Shares
50,000
Price
$0.77
Value
$38K
Patel Mahesh V.
CEO and President · Director
Date
Nov 18
Shares
25,000
Price
$1.09
Value
$27K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About LPCN insider trading
LPCN insider trades
Lipocine Inc. (LPCN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including LPCN. Over the past 12 months, 0 insiders have filed transactions with the SEC. LPCN insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Lipocine Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
LPCN insider trading · 5 questionsThe insiders of Lipocine Inc. (LPCN) include executives and directors such as LPCN, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026